WO2011036316A3 - Uso de extractos vegetales como prebióticos, composiciones y alimentos que los contienen - Google Patents

Uso de extractos vegetales como prebióticos, composiciones y alimentos que los contienen Download PDF

Info

Publication number
WO2011036316A3
WO2011036316A3 PCT/ES2010/000389 ES2010000389W WO2011036316A3 WO 2011036316 A3 WO2011036316 A3 WO 2011036316A3 ES 2010000389 W ES2010000389 W ES 2010000389W WO 2011036316 A3 WO2011036316 A3 WO 2011036316A3
Authority
WO
WIPO (PCT)
Prior art keywords
extracts
compostions
prebiotics
foods containing
plant extracts
Prior art date
Application number
PCT/ES2010/000389
Other languages
English (en)
French (fr)
Other versions
WO2011036316A2 (es
Inventor
Marcos Peñalver Mellado
José A. LÓPEZ MAS
Sergio A. Streitenberger
Pedro MARTÍNEZ ORTIZ
Original Assignee
Probelte Pharma, Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probelte Pharma, Sa filed Critical Probelte Pharma, Sa
Priority to JP2012530298A priority Critical patent/JP2013505283A/ja
Priority to EP10818442.5A priority patent/EP2481298A4/en
Publication of WO2011036316A2 publication Critical patent/WO2011036316A2/es
Publication of WO2011036316A3 publication Critical patent/WO2011036316A3/es
Priority to US13/428,621 priority patent/US20120269790A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0056Spread compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/02Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/70Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
    • A23L2/84Clarifying or fining of non-alcoholic beverages; Removing unwanted matter using microorganisms or biological material, e.g. enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/125Casei
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/51Bifidobacterium
    • A23V2400/515Animalis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención reivindica el uso de extractos vegetales de olivo (Olea europaea L.) y granado (Punica granatum) y de diversas combinaciones de dichos extractos, algunas adicionalmente incluyendo un probiótico, que posibilitan un efecto sinérgico entre los componentes bioactivos de los mismos, para la preparación de suplementos dietarios, alimentos/bebidas funcionales, aditivos alimentarios y medicamentos para su uso en el cuidado de la salud humana.
PCT/ES2010/000389 2009-09-23 2010-09-23 Uso de extractos vegetales como prebióticos, composiciones y alimentos que los contienen WO2011036316A2 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2012530298A JP2013505283A (ja) 2009-09-23 2010-09-23 プレバイオティックスとしての植物抽出物の使用、当該植物抽出物を含有する組成物及び食品
EP10818442.5A EP2481298A4 (en) 2009-09-23 2010-09-23 USE OF PLANT EXTRACTS AS PREBIOTICS, AND COMPOSITIONS AND FOODS WITH SUCH EXTRACTS
US13/428,621 US20120269790A1 (en) 2009-09-23 2012-03-23 Use of plant extracts as prebiotics, compositions and foods containing such extract

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200901931A ES2356536B1 (es) 2009-09-23 2009-09-23 Una composición de uso como prebiótico que contiene un extracto de granada y un alimento que incluye dicha composición.
ESP200901931 2009-09-23

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/428,621 Continuation-In-Part US20120269790A1 (en) 2009-09-23 2012-03-23 Use of plant extracts as prebiotics, compositions and foods containing such extract

Publications (2)

Publication Number Publication Date
WO2011036316A2 WO2011036316A2 (es) 2011-03-31
WO2011036316A3 true WO2011036316A3 (es) 2011-08-11

Family

ID=43778607

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2010/000389 WO2011036316A2 (es) 2009-09-23 2010-09-23 Uso de extractos vegetales como prebióticos, composiciones y alimentos que los contienen

Country Status (5)

Country Link
US (1) US20120269790A1 (es)
EP (1) EP2481298A4 (es)
JP (1) JP2013505283A (es)
ES (1) ES2356536B1 (es)
WO (1) WO2011036316A2 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012158048A1 (en) * 2011-05-16 2012-11-22 Vital Food Processors Limited A dietary supplement
RU2451506C1 (ru) * 2011-06-02 2012-05-27 Сергей Юрьевич Лешков Комбинация для лечения сахарного диабета и его осложнений
CN105592852B (zh) 2013-09-30 2019-07-19 太阳星光齿磨公司 肥胖抑制组合物
CN103655744B (zh) * 2013-12-06 2015-06-10 丛宁 一种腹可安片的制备方法及其在制备抑制小鼠淋巴瘤细胞yac-1细胞增殖药物中的应用
JP5778843B1 (ja) * 2014-11-14 2015-09-16 株式会社 伊藤園 容器詰果汁含有飲料及びその製造方法
WO2016099944A1 (en) * 2014-12-19 2016-06-23 Halo Life Science, Llc Use of ellagic acid dihydrate in pharmaceutical formulations to regulate blood glucose levels
JP6740548B2 (ja) * 2015-05-15 2020-08-19 公立大学法人岡山県立大学 ウロリチン類を含有する育毛剤、及び、ウロリチン類を含有する5αレダクターゼ活性阻害剤
JP2017014154A (ja) * 2015-07-01 2017-01-19 公立大学法人岡山県立大学 ウロリチン類を含有するヒアルロン酸産生促進剤
JP6799767B2 (ja) * 2015-07-07 2020-12-16 公立大学法人岡山県立大学 ウロリチン類を含有するメラニン産生抑制剤
GB201605013D0 (en) * 2016-03-24 2016-05-11 Inst Of Food Res S-methylcysteine sulfoxide for prostate cancer treatment
JP6791478B2 (ja) * 2016-05-26 2020-11-25 株式会社ダイセル ウロリチン類を含有するアンジオテンシン変換酵素阻害剤
US11857579B2 (en) 2018-03-23 2024-01-02 Morinaga Milk Industry Co., Ltd. Composition for promoting the secretion of FGF21
WO2019212997A1 (en) * 2018-04-30 2019-11-07 Rejuvenation Therapeutics Compositions and methods for biosynthetic preparation of urolithin compounds and use thereof
MY197227A (en) * 2018-08-17 2023-06-06 Malaysian Palm Oil Board Mpob Composition comprising oil palm phenolics for use in the treatment and prevention of colon diseases and for promoting and maintaining gut and general health
EP3646739A1 (en) * 2018-11-01 2020-05-06 N.V. Nutricia Nutritional composition comprising urea and non-digestible oligosaccharides
KR102682981B1 (ko) * 2018-11-05 2024-07-11 마블바이옴 인코포레이티드 엘라기탄닌을 포함하는 미생물 조성물 및 사용 방법
US20220160797A1 (en) * 2019-04-01 2022-05-26 North Carolina State University Probiotic bacteria capable of adaptive response to pomegranate extract and methods of production and use thereof
US11730778B2 (en) * 2019-09-24 2023-08-22 Access Business Group International Llc Method of increasing the level and production of metabolized phytonutrients in a subject
WO2022153203A1 (en) * 2021-01-13 2022-07-21 Esperer Onco Nutrition Private Limited Dini axis based products
CN113575946B (zh) * 2021-07-26 2024-06-14 仙乐健康科技股份有限公司 一种抑制糖分和脂肪吸收的组合物

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968505A (en) * 1995-09-15 1999-10-19 Johns Hopkins School Of Medicine Cancer chemoprotective food products
WO2004028460A2 (en) * 2002-09-26 2004-04-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
WO2005092127A1 (en) * 2004-03-11 2005-10-06 Glaxo Group Limited Prebiotic use of fruits and fruit juices in the promotion of beneficial gut microflora
EP1600061A1 (en) * 2004-05-25 2005-11-30 Cognis IP Management GmbH Oral and/or topical compositions
WO2009031023A2 (en) * 2007-09-07 2009-03-12 Probelte Pharma, S.A. Pomegranate extracts, nutritional products containing them and their uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7611738B2 (en) * 2005-05-24 2009-11-03 Pom Wonderful, Llc Processes for extracting phytochemicals from pomegranate solids and compositions and methods of use thereof
US7727563B2 (en) * 1999-04-19 2010-06-01 Pom Wonderful, Llc Methods of using pomegranate extracts for treating diabetes related atherosclerotic complications in humans
US20080050498A1 (en) * 2004-10-07 2008-02-28 Next Proteins, Inc. Powdered protein beverage mix and methods of making the same
EP1967078A1 (en) * 2007-03-08 2008-09-10 Probelte Pharma, S.A. Process and apparatus for preparing pomegranate extracts
US20100004334A1 (en) * 2008-07-01 2010-01-07 Mead Johnson Nutrition Company Nutritional Compositions Containing Punicalagins

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968505A (en) * 1995-09-15 1999-10-19 Johns Hopkins School Of Medicine Cancer chemoprotective food products
WO2004028460A2 (en) * 2002-09-26 2004-04-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
WO2005092127A1 (en) * 2004-03-11 2005-10-06 Glaxo Group Limited Prebiotic use of fruits and fruit juices in the promotion of beneficial gut microflora
EP1600061A1 (en) * 2004-05-25 2005-11-30 Cognis IP Management GmbH Oral and/or topical compositions
WO2009031023A2 (en) * 2007-09-07 2009-03-12 Probelte Pharma, S.A. Pomegranate extracts, nutritional products containing them and their uses

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DOBROSLAWA, B. ET AL.: "The effect of pomegranate (Punica granatum L.), byproducts and ellagitannins on the growth of human gut bacteria", J. AGRIC. FOOD CHEM, vol. 57, 25 August 2009 (2009-08-25), pages 8344 - 8449, XP008155280 *

Also Published As

Publication number Publication date
EP2481298A2 (en) 2012-08-01
ES2356536A1 (es) 2011-04-11
EP2481298A4 (en) 2013-10-23
JP2013505283A (ja) 2013-02-14
ES2356536B1 (es) 2012-02-13
WO2011036316A2 (es) 2011-03-31
US20120269790A1 (en) 2012-10-25

Similar Documents

Publication Publication Date Title
WO2011036316A3 (es) Uso de extractos vegetales como prebióticos, composiciones y alimentos que los contienen
BR112012001912A8 (pt) Composições nutritivas que compreendem fibra e probióticos
HK1252943A1 (zh) 可用於食品、飲食補充劑、化妝品和藥物製劑的呈現多種協同抗氧化劑活性的植物複合物
MX2011012066A (es) Complementos orales que comprenden probioticos.
JO2975B1 (en) Formulation to improve sexual health
NZ596584A (en) Probiotic juice drink comprising at least one species of lactobacillus and fruit juices
NO20085374L (no) Anvendelse av fytat som middel for a inhibere opplosning av krystaller av kalsiumsalter for forhindring av osteoporose
PL2809168T3 (pl) Wielowarstwowe mikrokapsułkowane bakterie probiotyczne oraz żywność i kompozycje farmaceutyczne zawierające te bakterie
PL2173195T3 (pl) Biomasa wzbogacona w cynk, sposób jej wytwarzania oraz zawierające ją produkty probiotyczne, kosmetyczne, dietetyczne i nutraceutyczne
MX2014004722A (es) Composicion para ser usada en la promocion del crecimiento de hueso sano y/o en la prevencion y/o tratamiento de la enfermedad osea.
MX2018002543A (es) Composiciones que comprenden compuestos de urolitina.
UA102811C2 (uk) Протимікробні міцели для застосування у харчових продуктах
MX2015015628A (es) Acido graso del aceite de bogol para uso en suplementos y composiciones de tratamiento y piensos para animales.
PH12014502811A1 (en) Dietary management of celiac disease and food allergy
MX357554B (es) Concentrado o extracto de brote de aloe vera que tiene efectos superiores de promoción de célula de la piel, antioxidantes y anti-alergia.
HK1161038A1 (en) Nutritional supplements for 50 individuals for improving vitality, immunity, eye and bone health 50
AR100313A1 (es) Composiciones nutricionales dirigidas a sujetos con alergias a la proteína de la leche de vaca
WO2012030841A3 (en) Improved means of supplying essential elements and nutrients
MX2013004371A (es) Cisteina y consumo de alimentos.
WO2011019875A3 (en) Antioxidant dietary supplement compositions
SG11201506037WA (en) Bioactive compositions from theacea plants and use thereof in beverages, functional foods, nutriceuticals, supplements and the like
WO2011042501A3 (en) Glp-2 for use in intestine and muscle recovery
PL2317872T3 (pl) Biomasa wzbogacona w miedź, sposób jej wytwarzania oraz produkty probiotyczne, kosmetyczne, dietetyczne i nutraceutyczne ją zawierające
MY188896A (en) Methods and compositions for reducing digestive/absorptive rates and ratio of food/drinks or reducing a digestive solution
PT2477633E (pt) Suplemento dietético que estimula a função sexual masculina

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2012530298

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2010818442

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2010818442

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10818442

Country of ref document: EP

Kind code of ref document: A2